Xcout Intel
IMAGINAB, INC.
ImaginAb, Inc. is a global biotechnology company headquartered in California, with operations in Los Angeles and San Diego. It focuses on developing next-generation imaging and radiopharmaceutical products for cancer immunology.
Subscribe to see IMAGINAB, INC.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
IMAGINAB, INC. at a glance
IMAGINAB, INC. is a biotechnology company headquartered in United States. It has raised at least $26.3M across the 3 funding rounds on record. Its most recent funding round, Growth, raised $13M in June 2021. Xcout tracks 8 named people at IMAGINAB, INC., including David Fractor (Chief Financial Officer).
IMAGINAB, INC. leadership
- David FractorChief Financial Officer
- Anna M. WuFounder and Chief Scientific Advisor
- Jill DurkinVP, Financial Strategy and Planning
- Kristin SchmiedehausenVP, Medical Affairs
- Kathleen BradyAssociate Director, Quality Assurance
- Friedhelm BlobelIndependent Non-Executive Director
2 more named people on record for IMAGINAB, INC., with roles, board committees and tenure — see the full roster →
IMAGINAB, INC. funding rounds
At least $26.3M raised across the 3 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Growth | $13M | 6 named | |
| — | $8M | 1 named | |
| SEC Form D filing | $5.3M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
IMAGINAB, INC. competitors
A few of IMAGINAB, INC.'s closest competitors — see the full list of competitors and alternatives →
ABSCINT is a clinical-stage biotechnology company that develops platform production processes for rapid creation of cold kits for molecular imaging in oncology and immunology. Headquartered in Belgium, the privately held firm focuses on innovative diagnostic and therapeutic applications using single-domain antibodies.
On Target Laboratories, Inc. is a biotechnology company founded in 2010 and headquartered in West Lafayette, Indiana. It discovers and develops targeted intraoperative molecular imaging agents to illuminate cancer during surgery.
Spago Nanomedical is a clinical-stage pharmaceutical company that develops precision nanomedicine products for the diagnosis and treatment of cancer and other severe diseases. Its pipeline includes Tumorad, a targeted radionuclide therapy for various cancers, and SpagoPix, a polymeric contrast agent designed to improve the precision of MRI diagnostics.
ImmunityBio, Inc. is a public clinical-stage immunotherapy company headquartered in San Diego, California. As a member of the NantWorks ecosystem, it focuses on developing next-generation cancer vaccines and immunotherapies.
Inmagene Biopharmaceuticals is a clinical-stage biotechnology company headquartered in San Diego, California. The firm is dedicated to the research, development, and advancement of novel therapeutic medicines. It operates within the life sciences sector, focusing on clinical development and corporate mergers.
Theragene Pharmaceuticals, Inc. is a privately held biopharmaceutical company headquartered in Los Angeles, California, focusing on immunotherapy technologies.
Get IMAGINAB, INC.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on IMAGINAB, INC. in Xcout Intel
- 8 named people with titles, LinkedIn and board committees
- 3 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access